Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Rating) dropped 5.4% on Monday . The stock traded as low as $14.23 and last traded at $14.26. Approximately 370,565 shares changed hands during trading, a decline of 70% from the average daily volume of 1,232,354 shares. The stock had previously closed at $15.08. Wall Street Analyst […]
Lazard Asset Management LLC increased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Get Rating) by 70.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,545 shares of the company’s stock after buying an additional 1,877 shares during […]
Scotiabank assumed coverage on shares of Twist Bioscience (NASDAQ:TWST – Get Rating) in a research report sent to investors on Wednesday, The Fly reports. The brokerage issued an outperform rating on the stock. Other research analysts also recently issued research reports about the company. Robert W. Baird reduced their price target on Twist Bioscience from […]
Twist Bioscience (NASDAQ:TWST – Get Rating) and Seagen (NASDAQ:SGEN – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings. Earnings and Valuation This table compares Twist Bioscience and Seagen’s top-line […]
Twist Bioscience Co. (NASDAQ:TWST – Get Rating) SVP Paula Green sold 10,067 shares of the firm’s stock in a transaction on Wednesday, June 15th. The shares were sold at an average price of $30.47, for a total transaction of $306,741.49. Following the transaction, the senior vice president now directly owns 14,727 shares of the company’s […]